Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

Schatz, Robin A

Schatz, Robin A.

Affiliation

Schatz RA; College of Pharmacy, The University of Toledo, Toledo, OH, USA. robinschatz@msn.com

Ann Pharmacother ; 37(9): 1321-4, 2003 Sep.

Article in En | MEDLINE | ID: mdl-12921516

Subject(s)

Alzheimer Disease/drug therapy; Antipsychotic Agents/therapeutic use; Mental Disorders/drug therapy; Pirenzepine/analogs & derivatives; Pirenzepine/therapeutic use; Psychotic Disorders/drug therapy; Alzheimer Disease/complications; Alzheimer Disease/psychology; Benzodiazepines; Humans; Mental Disorders/etiology; Mental Disorders/psychology; Olanzapine; Psychotic Disorders/etiology; Psychotic Disorders/psychology; Randomized Controlled Trials as Topic; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Antipsychotic Agents / Pirenzepine / Alzheimer Disease / Mental Disorders Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links